Chronic mucocutaneous candidiasis (CMC) is a monogenetic immunodeficiency of cell-mediated immunity that develops as a consequence of defects in IL-17 and IL-22 immunity required for defence against fungal infections [43]. This evidence concerns the gene IL17A and chronic mucocutaneous candidiasis.